David M. Brown
Impact in
- Ophthalmology top 0.01%
- Retinal Diseases and Treatments
- Retinal and Optic Conditions
- Glaucoma and retinal disorders
- Ocular Diseases and Behçet’s Syndrome
- Radiology, Nuclear Medicine and Imaging top 0.05%
- Retinal Imaging and Analysis
- Retinal and Macular Surgery
Papers in
- Ophthalmology 112
- Retinal Diseases and Treatments 105
- Retinal and Optic Conditions 70
- Glaucoma and retinal disorders 24
-
- Retinal Imaging and Analysis 74
- Retinal and Macular Surgery 15
- Co-authors
- David S. BoyerVicki StoneRoman G. RubioPeter A. CampochiaroJeffrey S. HeierCharles C. WykoffAmy Chen RundleNamrata Saroj
- Journals
- Ophthalmology (28 papers)Investigative Ophthalmology & Visual Science (17 papers)Diabetes (14 papers)Retina (14 papers)Ophthalmology Retina (12 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
David M. Brown
289 papers receiving 14.6k citations
Hit Papers
Peers
Comparison fields: 5 of 184
- Ophthalmology 8.7k
- Radiology, Nuclear Medicine and Imaging 6.5k
- Nephrology 542
- Health, Toxicology and Mutagenesis 878
- Clinical Biochemistry 338
Countries citing papers authored by David M. Brown
This map shows the geographic impact of David M. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Brown more than expected).
Fields of papers citing papers by David M. Brown
This network shows the impact of papers produced by David M. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Brown. The network helps show where David M. Brown may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David M. Brown, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 21 | |
| 7 | 2022 | 4 | |
| 8 | Posterior Vitreous Detachment Assessment by Age Using Circumpapillary Optical Coherence Tomography | 2021 | 1 |
| 9 | Correlation of Intraocular Cytokine Expression with Quantitative Ultra-widefield Fluorescein Angiographic Features in the IMAGINE Retinal Vein Occlusion Study | 2021 | 1 |
| 10 | 2020 | 6 | |
| 11 | Longitudinal Changes in Aqueous Humor Cytokines in Diabetic Macular Edema Treated with Anti-Vascular Endothelial Growth Factor Therapy | 2020 | 1 |
| 12 | 2019 | 14 | |
| 13 | 2019 | 7 | |
| 14 | 2019 | 4 | |
| 15 | 2018 | 12 | |
| 16 | Multicenter, Prospective Trial Comparing Treat & Extend to Monthly Dosing in Neovascular AMD Management: TREX-AMD 12-Month Outcomes | 2015 | 1 |
| 17 | Ocriplasmin for Vitreomacular Adhesion (VMA) in the Clinical Setting: Rates of VMA Release, Development of Macular Holes, and Visual Outcomes | 2014 | 2 |
| 18 | Correlation between changes in OCT and visual acuity in the management of neovascular AMD: Does subretinal fluid matter? | 2013 | 2 |
| 19 | Randomized, Double-masked, Active-controlled Phase 3 Trial Of The Efficacy And Safety Of Intravitreal VEGF Trap-Eye In Wet AMD: One-year Results Of The View-1 Study | 2011 | 8 |
| 20 | DA VINCI: DME and VEGF Trap-Eye: INvestigation of Clinical Impact: Phase 2 Study in Patients With Diabetic Macular Edema (DME) | 2010 | 2 |
About David M. Brown
David M. Brown is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging, Health, Toxicology and Mutagenesis, Nephrology and Complementary and Manual Therapy, having authored 296 papers that have together received 15.4k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (105 papers), Retinal Imaging and Analysis (74 papers), Retinal and Optic Conditions (70 papers), Nanoparticles: synthesis and applications (34 papers), Air Quality and Health Impacts (27 papers), Glaucoma and retinal disorders (24 papers), Occupational and environmental lung diseases (18 papers) and Retinal and Macular Surgery (15 papers). The work is most often cited by research in Ophthalmology (8.7k citations), Radiology, Nuclear Medicine and Imaging (6.5k citations), Nephrology (542 citations), Health, Toxicology and Mutagenesis (878 citations) and Clinical Biochemistry (338 citations). David M. Brown has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include David S. Boyer, Vicki Stone, Roman G. Rubio, Peter A. Campochiaro, Jeffrey S. Heier, Charles C. Wykoff, Amy Chen Rundle, Namrata Saroj, Sarah Gray and Quan Dong Nguyen. Their work appears in journals such as Ophthalmology, Investigative Ophthalmology & Visual Science, Diabetes, Retina and Ophthalmology Retina.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.